AST 0 3 0 3 B-clinical_variable
/ 3 4 3 4 O
ALT 4 7 4 7 B-clinical_variable
≤ 8 9 8 9 O
3X 10 12 10 12 B-upper_bound
ULN 13 16 13 16 I-upper_bound
( 17 18 17 18 I-upper_bound
upper 18 23 18 23 I-upper_bound
limit 24 29 24 29 I-upper_bound
of 30 32 30 32 I-upper_bound
normal 33 39 33 39 I-upper_bound
) 39 40 39 40 I-upper_bound
AST 41 44 41 44 O
/ 44 45 44 45 O
ALT 45 48 45 48 O
≤ 49 50 49 50 O
5X 51 53 51 53 B-upper_bound
ULN 54 57 54 57 I-upper_bound
[ 58 59 58 59 O
with 59 63 59 63 O
underlying 64 74 64 74 O
liver 75 80 75 80 B-cancer
metastasis 81 91 81 91 I-cancer
] 91 92 91 92 O
Total 93 98 93 98 B-clinical_variable
bilirubin 99 108 99 108 I-clinical_variable
≤ 109 110 109 110 O
2.0 111 114 111 114 B-upper_bound
X 115 116 115 116 I-upper_bound
ULN 117 120 117 120 I-upper_bound
Serum 121 126 121 126 B-clinical_variable
creatinine 127 137 127 137 I-clinical_variable
≤ 138 139 138 139 O
1.5X 140 144 140 144 B-upper_bound
ULN 145 148 145 148 I-upper_bound
ANC 149 152 149 152 B-clinical_variable
≥ 153 154 153 154 O
1500 155 159 155 159 B-lower_bound
/µL 160 163 160 163 I-lower_bound
Platelets 164 173 164 173 B-clinical_variable
> 174 175 174 175 O
100,000/µL 176 186 176 186 B-lower_bound

Another 0 7 187 194 O
investigational 8 23 195 210 B-treatment
drug 24 28 211 215 I-treatment

Chemotherapeutic 0 16 216 232 B-treatment
Agent 17 22 233 238 I-treatment

Cohort 0 6 239 245 O
Expansion 7 16 246 255 O
Phase 17 22 256 261 O
: 22 23 261 262 O
Subjects 24 32 263 271 O
with 33 37 272 276 O
asymptomatic 38 50 277 289 O
CNS 51 54 290 293 B-cancer
metastases 55 65 294 304 I-cancer
for 66 69 305 308 O
at 70 72 309 311 O
least 73 78 312 317 O
four 79 83 318 322 B-lower_bound
weeks 84 89 323 328 I-lower_bound
before 90 96 329 335 I-lower_bound
study 97 102 336 341 B-treatment
drug 103 107 342 346 I-treatment
treatment 108 117 347 356 I-treatment

Dose 0 4 357 361 O
Escalation 5 15 362 372 O
Phase 16 21 373 378 O
: 21 22 378 379 O
No 23 25 380 382 O
known 26 31 383 388 O
central 32 39 389 396 B-cancer
nervous 40 47 397 404 I-cancer
system 48 54 405 411 I-cancer
( 55 56 412 413 I-cancer
CNS 56 59 413 416 I-cancer
) 59 60 416 417 I-cancer
metastases 61 71 418 428 I-cancer
or 72 74 429 431 O
neurological 75 87 432 444 O
symptoms 88 96 445 453 O
possibly 97 105 454 462 O
related 106 113 463 470 O
to 114 116 471 473 O
active 117 123 474 480 O
CNS 124 127 481 484 B-cancer
metastasis 128 138 485 495 I-cancer
in 139 141 496 498 O
Dose 142 146 499 503 O
Escalation 147 157 504 514 O
Phase 158 163 515 520 O

Histologically 0 14 521 535 O
or 15 17 536 538 O
cytologically 18 31 539 552 O
confirmed 32 41 553 562 O
diagnosis 42 51 563 572 O
of 52 54 573 575 O
Globo 55 60 576 581 B-cancer
H 61 62 582 583 I-cancer
- 62 63 583 584 I-cancer
positive 63 71 584 592 I-cancer
NSCLC 72 77 593 598 I-cancer

Histologically 0 14 599 613 O
or 15 17 614 616 O
cytologically 18 31 617 630 O
confirmed 32 41 631 640 O
diagnosis 42 51 641 650 O
of 52 54 651 653 O
gastric 55 62 654 661 B-cancer
, 62 63 661 662 O
lung 64 68 663 667 B-cancer
, 68 69 667 668 O
colorectal 70 80 669 679 B-cancer
or 81 83 680 682 O
breast 84 90 683 689 B-cancer
cancer 91 97 690 696 I-cancer
on 98 100 697 699 O
file 101 105 700 704 O

IV 0 2 705 707 B-treatment
/ 2 3 707 708 O
oral 3 7 708 712 B-treatment
steroids 8 16 713 721 I-treatment
except 17 23 722 728 O
single 24 30 729 735 O
prophylactic 31 43 736 748 O
use 44 47 749 752 O
in 48 50 753 755 O
CT 51 53 756 758 O
/ 53 54 758 759 O
MRI 54 57 759 762 O
scan 58 62 763 767 O
or 63 65 768 770 O
other 66 71 771 776 O
one 72 75 777 780 O
- 75 76 780 781 O
time 76 80 781 785 O
use 81 84 786 789 O
in 85 87 790 792 O
approved 88 96 793 801 O
indications 97 108 802 813 O

Immunosuppressants 0 18 814 832 B-treatment
( 19 20 833 834 O
e.g. 20 24 834 838 O
, 24 25 838 839 O
cyclosporin 26 37 840 851 B-treatment
, 37 38 851 852 O
rapamycin 39 48 853 862 B-treatment
, 48 49 862 863 O
tacrolimus 50 60 864 874 B-treatment
, 60 61 874 875 O
rituximab 62 71 876 885 B-treatment
, 71 72 885 886 O
alemtuzumab 73 84 887 898 B-treatment
, 84 85 898 899 O
natalizumab 86 97 900 911 B-treatment
, 97 98 911 912 O
etc 99 102 913 916 O
. 102 103 916 917 O
) 103 104 917 918 O

Immunotherapy 0 13 919 932 B-treatment
[ 14 15 933 934 O
Interferons 15 26 934 945 B-treatment
, 26 27 945 946 O
Cytokines 28 37 947 956 B-treatment
] 37 38 956 957 O
( 39 40 958 959 O
except 40 46 959 965 O
PD-1 47 51 966 970 B-treatment
/ 51 52 970 971 I-treatment
PD 52 54 971 973 I-treatment
- 54 55 973 974 I-treatment
L1 55 57 974 976 I-treatment
antagonists 58 69 977 988 I-treatment
) 69 70 988 989 O

Immunotherapy 0 13 990 1003 B-treatment
[ 14 15 1004 1005 O
mAbs 15 19 1005 1009 B-treatment
, 19 20 1009 1010 O
Interferons 21 32 1011 1022 B-treatment
, 32 33 1022 1023 O
Cytokines 34 43 1024 1033 B-treatment
( 44 45 1034 1035 O
except 45 51 1035 1041 O
GCSF 52 56 1042 1046 B-treatment
) 56 57 1046 1047 O
] 57 58 1047 1048 O

Patients 0 8 1049 1057 O
who 9 12 1058 1061 O
have 13 17 1062 1066 O
not 18 21 1067 1070 O
received 22 30 1071 1079 O
standard 31 39 1080 1088 B-treatment
chemotherapy 40 52 1089 1101 I-treatment
, 52 53 1101 1102 O
hormonal 54 62 1103 1111 B-treatment
or 63 65 1112 1114 I-treatment
targeted 66 74 1115 1123 I-treatment
therapy 75 82 1124 1131 I-treatment
for 83 86 1132 1135 O
their 87 92 1136 1141 O
underlying 93 103 1142 1152 O
advanced 104 112 1153 1161 B-cancer
/ 112 113 1161 1162 I-cancer
metastatic 113 123 1162 1172 I-cancer
cancer 124 130 1173 1179 I-cancer

Performance 0 11 1180 1191 B-clinical_variable
status 12 18 1192 1198 I-clinical_variable
: 18 19 1198 1199 I-clinical_variable
ECOG 20 24 1200 1204 I-clinical_variable
≤ 25 26 1205 1206 O
1 27 28 1207 1208 B-upper_bound

Subjects 0 8 1209 1217 O
of 9 11 1218 1220 O
child 12 17 1221 1226 O
- 17 18 1226 1227 O
bearing 18 25 1227 1234 O
potential 26 35 1235 1244 O
must 36 40 1245 1249 O
agree 41 46 1250 1255 B-contraception_consent
to 47 49 1256 1258 I-contraception_consent
use 50 53 1259 1262 I-contraception_consent
acceptable 54 64 1263 1273 I-contraception_consent
contraceptive 65 78 1274 1287 I-contraception_consent
methods 79 86 1288 1295 I-contraception_consent
during 87 93 1296 1302 O
treatment 94 103 1303 1312 B-treatment
and 104 107 1313 1316 O
until 108 113 1317 1322 O
the 114 117 1323 1326 O
end 118 121 1327 1330 O
of 122 124 1331 1333 O
the 125 128 1334 1337 O
study 129 134 1338 1343 O

Subjects 0 8 1344 1352 O
who 9 12 1353 1356 O
are 13 16 1357 1360 B-pregnancy
pregnant 17 25 1361 1369 I-pregnancy
or 26 28 1370 1372 O
breast 29 35 1373 1379 O
- 35 36 1379 1380 O
feeding 36 43 1380 1387 O
at 44 46 1388 1390 O
entry 47 52 1391 1396 O

Subjects 0 8 1397 1405 O
with 9 13 1406 1410 O
HIV 14 17 1411 1414 B-chronic_disease
infection 18 27 1415 1424 I-chronic_disease
, 27 28 1424 1425 O
active 29 35 1426 1432 O
hepatitis 36 45 1433 1442 B-chronic_disease
B 46 47 1443 1444 I-chronic_disease
infection 48 57 1445 1454 I-chronic_disease
or 58 60 1455 1457 O
active 61 67 1458 1464 O
hepatitis 68 77 1465 1474 B-chronic_disease
C 78 79 1475 1476 I-chronic_disease
infection 80 89 1477 1486 I-chronic_disease

Subjects 0 8 1487 1495 O
with 9 13 1496 1500 O
any 14 17 1501 1504 O
autoimmune 18 28 1505 1515 B-chronic_disease
disorders 29 38 1516 1525 I-chronic_disease
requiring 39 48 1526 1535 O
iv 49 51 1536 1538 B-treatment
/ 51 52 1538 1539 O
oral 52 56 1539 1543 B-treatment
steroids 57 65 1544 1552 I-treatment
or 66 68 1553 1555 O
immunosuppressive 69 86 1556 1573 B-treatment
or 87 89 1574 1576 O
immunomodulatory 90 106 1577 1593 B-treatment
therapies 107 116 1594 1603 I-treatment

Subjects 0 8 1604 1612 O
with 9 13 1613 1617 O
any 14 17 1618 1621 O
known 18 23 1622 1627 O
severe 24 30 1628 1634 O
allergies 31 40 1635 1644 O
( 41 42 1645 1646 O
e.g. 42 46 1646 1650 O
, 46 47 1650 1651 O
anaphylaxis 48 59 1652 1663 B-allergy_name
) 59 60 1663 1664 O
to 61 63 1665 1667 O
any 64 67 1668 1671 O
active 68 74 1672 1678 O
or 75 77 1679 1681 O
inactive 78 86 1682 1690 O
ingredients 87 98 1691 1702 O
in 99 101 1703 1705 O
the 102 105 1706 1709 O
study 106 111 1710 1715 B-treatment
drugs 112 117 1716 1721 I-treatment

Subjects 0 8 1722 1730 O
with 9 13 1731 1735 O
any 14 17 1736 1739 O
known 18 23 1740 1745 O
uncontrolled 24 36 1746 1758 O
inter 37 42 1759 1764 B-chronic_disease
- 42 43 1764 1765 I-chronic_disease
current 43 50 1765 1772 I-chronic_disease
illness 51 58 1773 1780 I-chronic_disease
including 59 68 1781 1790 O
ongoing 69 76 1791 1798 O
or 77 79 1799 1801 O
active 80 86 1802 1808 B-chronic_disease
infections 87 97 1809 1819 I-chronic_disease
, 97 98 1819 1820 O
symptomatic 99 110 1821 1832 O
congestive 111 121 1833 1843 B-chronic_disease
heart 122 127 1844 1849 I-chronic_disease
failure 128 135 1850 1857 I-chronic_disease
( 136 137 1858 1859 O
NYHA>2 137 143 1859 1865 B-clinical_variable
) 143 144 1865 1866 O
, 144 145 1866 1867 O
unstable 146 154 1868 1876 B-chronic_disease
angina 155 161 1877 1883 I-chronic_disease
pectoris 162 170 1884 1892 I-chronic_disease
, 170 171 1892 1893 O
cardiac 172 179 1894 1901 B-chronic_disease
arrhythmia 180 190 1902 1912 I-chronic_disease
, 190 191 1912 1913 O
or 192 194 1914 1916 O
psychiatric 195 206 1917 1928 B-chronic_disease
illness 207 214 1929 1936 I-chronic_disease
/ 214 215 1936 1937 O
social 215 221 1937 1943 B-chronic_disease
situations 222 232 1944 1954 I-chronic_disease
that 233 237 1955 1959 O
would 238 243 1960 1965 O
limit 244 249 1966 1971 O
compliance 250 260 1972 1982 O
with 261 265 1983 1987 O
study 266 271 1988 1993 O
requirements 272 284 1994 2006 O

Subjects 0 8 2007 2015 O
with 9 13 2016 2020 O
any 14 17 2021 2024 O
of 18 20 2025 2027 O
the 21 24 2028 2031 O
following 25 34 2032 2041 O
MEDICATIONS 35 46 2042 2053 B-treatment
within 47 53 2054 2060 O
4 54 55 2061 2062 B-upper_bound
weeks 56 61 2063 2068 I-upper_bound
prior 62 67 2069 2074 I-upper_bound
to 68 70 2075 2077 O
IP 71 73 2078 2080 B-treatment
treatment 74 83 2081 2090 I-treatment

Subjects 0 8 2091 2099 O
with 9 13 2100 2104 O
known 14 19 2105 2110 O
or 20 22 2111 2113 O
clinically 23 33 2114 2124 O
manifest 34 42 2125 2133 O
, 42 43 2133 2134 O
symptomatic 44 55 2135 2146 O
CNS 56 59 2147 2150 B-cancer
metastases 60 70 2151 2161 I-cancer
in 71 73 2162 2164 O
Dose 74 78 2165 2169 O
Escalation 79 89 2170 2180 O
Phase 90 95 2181 2186 O

Subjects 0 8 2187 2195 O
with 9 13 2196 2200 O
pleural 14 21 2201 2208 B-chronic_disease
effusions 22 31 2209 2218 I-chronic_disease
and/or 32 38 2219 2225 O
ascites 39 46 2226 2233 B-chronic_disease
, 46 47 2233 2234 O
due 48 51 2235 2238 O
to 52 54 2239 2241 O
malignancy 55 65 2242 2252 B-cancer
, 65 66 2252 2253 O
requiring 67 76 2254 2263 O
paracentesis 77 89 2264 2276 B-chronic_disease
every 90 95 2277 2282 O
2 96 97 2283 2284 B-lower_bound
weeks 98 103 2285 2290 I-lower_bound
or 104 106 2291 2293 O
more 107 111 2294 2298 O
frequently 112 122 2299 2309 O

Subjects 0 8 2310 2318 O
with 9 13 2319 2323 O
splenectomy 14 25 2324 2335 B-treatment

The 0 3 2336 2339 O
interval 4 12 2340 2348 O
between 13 20 2349 2356 O
IV 21 23 2357 2359 B-treatment
/ 23 24 2359 2360 I-treatment
oral 24 28 2360 2364 I-treatment
steroids 29 37 2365 2373 I-treatment
administration 38 52 2374 2388 O
and 53 56 2389 2392 O
first 57 62 2393 2398 O
dose 63 67 2399 2403 O
of 68 70 2404 2406 O
OBI-833 71 78 2407 2414 B-treatment
/ 78 79 2414 2415 O
OBI-821 79 86 2415 2422 B-treatment
must 87 91 2423 2427 O
be 92 94 2428 2430 O
more 95 99 2431 2435 O
than 100 104 2436 2440 O
pharmacological 105 120 2441 2456 O
duration 121 129 2457 2465 O
or 130 132 2466 2468 O
5 133 134 2469 2470 B-lower_bound
half 135 139 2471 2475 I-lower_bound
- 139 140 2475 2476 I-lower_bound
lives 140 145 2476 2481 I-lower_bound
of 146 148 2482 2484 O
administered 149 161 2485 2497 O
steroids 162 170 2498 2506 O
, 170 171 2506 2507 O
whichever 172 181 2508 2517 O
is 182 184 2518 2520 O
longer 185 191 2521 2527 O

The 0 3 2528 2531 O
interval 4 12 2532 2540 O
between 13 20 2541 2548 O
IV 21 23 2549 2551 B-treatment
/ 23 24 2551 2552 O
oral 24 28 2552 2556 B-treatment
steroids 29 37 2557 2565 I-treatment
administration 38 52 2566 2580 O
and 53 56 2581 2584 O
first 57 62 2585 2590 O
dose 63 67 2591 2595 O
of 68 70 2596 2598 O
OBI-833 71 78 2599 2606 O
/ 78 79 2606 2607 O
OBI-821 79 86 2607 2614 O
must 87 91 2615 2619 O
be 92 94 2620 2622 O
more 95 99 2623 2627 O
than 100 104 2628 2632 O
pharmacological 105 120 2633 2648 O
duration 121 129 2649 2657 O
or 130 132 2658 2660 O
5 133 134 2661 2662 O
half 135 139 2663 2667 O
- 139 140 2667 2668 O
lives 140 145 2668 2673 O
of 146 148 2674 2676 O
administered 149 161 2677 2689 O
steroids 162 170 2690 2698 O
, 170 171 2698 2699 O
whichever 172 181 2700 2709 O
is 182 184 2710 2712 O
the 185 188 2713 2716 O
longer 189 195 2717 2723 O

Type 0 4 2724 2728 O
1 5 6 2729 2730 O
juvenile 7 15 2731 2739 O
onset 16 21 2740 2745 O
diabetes 22 30 2746 2754 B-chronic_disease
mellitus 31 39 2755 2763 I-chronic_disease
, 39 40 2763 2764 O
antibody 41 49 2765 2773 O
positive 50 58 2774 2782 O
for 59 62 2783 2786 O
rheumatoid 63 73 2787 2797 B-chronic_disease
arthritis 74 83 2798 2807 I-chronic_disease
, 83 84 2807 2808 O
Grave 85 90 2809 2814 B-chronic_disease
's 90 92 2814 2816 I-chronic_disease
disease 93 100 2817 2824 I-chronic_disease
, 100 101 2824 2825 O
Hashimoto 102 111 2826 2835 B-chronic_disease
's 111 113 2835 2837 I-chronic_disease
thyroiditis 114 125 2838 2849 I-chronic_disease
, 125 126 2849 2850 O
lupus 127 132 2851 2856 B-chronic_disease
, 132 133 2856 2857 O
scleroderma 134 145 2858 2869 B-chronic_disease
, 145 146 2869 2870 O
systemic 147 155 2871 2879 O
vasculitis 156 166 2880 2890 B-chronic_disease
, 166 167 2890 2891 O
hemolytic 168 177 2892 2901 B-chronic_disease
anemia 178 184 2902 2908 I-chronic_disease
, 184 185 2908 2909 O
immune 186 192 2910 2916 B-chronic_disease
mediated 193 201 2917 2925 I-chronic_disease
thrombocytopenia 202 218 2926 2942 I-chronic_disease
, 218 219 2942 2943 O
etc 220 223 2944 2947 O

Uses 0 4 2948 2952 O
of 5 7 2953 2955 O
inhaled 8 15 2956 2963 O
and 16 19 2964 2967 O
topical 20 27 2968 2975 B-treatment
steroids 28 36 2976 2984 I-treatment
are 37 40 2985 2988 O
allowed 41 48 2989 2996 O

Uses 0 4 2997 3001 O
of 5 7 3002 3004 O
inhaled 8 15 3005 3012 O
and 16 19 3013 3016 O
topical 20 27 3017 3024 O
use 28 31 3025 3028 O
of 32 34 3029 3031 O
steroids 35 43 3032 3040 B-treatment
are 44 47 3041 3044 O
allowed 48 55 3045 3052 O

≥21 0 3 3053 3056 O
years 4 9 3057 3062 I-lower_bound
of 10 12 3063 3065 O
age 13 16 3066 3069 B-age

